Cargando…
Neuroendocrine and Aggressive-Variant Prostate Cancer
SIMPLE SUMMARY: Prostate cancer may in some cases exhibit microscopic and molecular characteristics of a distinct subtype of disease which is referred to as neuroendocrine differentiation. This entity is rarely found in patients initially diagnosed with metastatic disease and most commonly occurs af...
Autores principales: | Spetsieris, Nicholas, Boukovala, Myrto, Patsakis, Georgios, Alafis, Ioannis, Efstathiou, Eleni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7765615/ https://www.ncbi.nlm.nih.gov/pubmed/33339136 http://dx.doi.org/10.3390/cancers12123792 |
Ejemplares similares
-
Aggressive variants of prostate cancer: underlying mechanisms of neuroendocrine transdifferentiation
por: Merkens, Lina, et al.
Publicado: (2022) -
A phase 2 trial of avelumab in men with aggressive-variant or neuroendocrine prostate cancer
por: Brown, Landon C., et al.
Publicado: (2022) -
Androgen-deprivation therapy-induced aggressive prostate cancer with neuroendocrine differentiation
por: Lipianskaya, Julia, et al.
Publicado: (2014) -
Morphologic, Molecular and Clinical Features of Aggressive Variant Prostate Cancer
por: Montironi, Rodolfo, et al.
Publicado: (2020) -
Function of Tumor Suppressors in Resistance to Antiandrogen Therapy and Luminal Epithelial Plasticity of Aggressive Variant Neuroendocrine Prostate Cancers
por: Soundararajan, Rama, et al.
Publicado: (2018)